SUMMARY A patient who had developed a factor VIII antibody three weeks after the birth of her first baby became pregnant for the second time 10 (1970) showed that these inhibitors were immunoglobulins as are the factor VIII antibodies found in treated haemophiliacs (Leitner et al., 1963) .
SUMMARY A patient who had developed a factor VIII antibody three weeks after the birth of her first baby became pregnant for the second time 10 weeks later. The pregnancy was normal apart from extensive spontaneous bruising during the first two months. This bleeding tendency disappeared in the third month of gestation and the antibody became undetectable during the eighth month. It had not reappeared seven months later. An unexplained long bleeding time and low platelet count were noted during the last trimester. The literature on postpartum coagulation inhibitors is reviewed.
Factor VIII antibody is a rare cause of haemorrhage in previously healthy postpartum women. Women who may have had this type of haemorrhagic disorder were reported by Rosenthal etal. (1937) and by Madison and Quick (1945) . The nature of the defect was first reported in 1946 when the plasma of two such patients was shown not only to resemble haemophilic plasma but to have an inhibitory effect on normal clotting (Fantl and Nance, 1946; Chargaff and West, 1946) . Dreskin and Rosenthal (1950) and Frick (1953) , studying similar postpartum inhibitors, demonstrated that they were directed against antihaemophilic factor. Shapiro (1967) and Robboy et al. (1970) showed that these inhibitors were immunoglobulins as are the factor VIII antibodies found in treated haemophiliacs (Leitner et al., 1963) .
We describe a patient with a postpartum factor VIII inhibitor who became pregnant again at a time when her factor VIII level was extremely low and while haemorrhagic manifestations were still present. (1959) . Platelet counts were performed manually and the bleeding time was measured by Ivy's method. Platelet aggregation was performed on fresh platelet-rich plasma in a Born-Michal aggregometer and platelet retention by Bowie's method with glass bead columns (Bowie et al., 1969) . Von Willebrand factor (VIII:WF) was assayed by the method of Weiss et al. (1973) . Factor VIII related antigen (VIIIR :AG) was determined by immunoelectrophoresis (Laurell, 928 group.bmj.com on October 29, 2017 -Published by http://jcp.bmj.com/ Downloaded from 1966). Platelet-bound IgG and serum anti-platelet antibody were tested by a quantitative complement lysis inhibition assay (Dixon et al., 1975) and antiplatelet agglutinins by a modification of the method of Dausset (1954) .
Results
Factor VIII:C, factor VIII antibody levels, platelet counts, and bleeding times during and after the second pregnancy are shown in the Figure. Immediately after the second baby was born the factor VIII:C level of the mother was 92 IU/dl and antibody to factor VIII was not detectable. In the postnatal period the mother's factor VIII :C fell to just below normal but antibody to factor VIII did not reappear, and the factor VIII :C Table. Nearly all the inhibitors tested were found to be directed against factor VIII. Only two were found to be anti-factor IX antibodies (Marmont et al., 1969; Ozsoylu and Ozer, 1973) . The antibody was usually detected within a few months of the delivery and disappeared spontaneously after a variable time, ranging from four months to more than 10 years. There is only one report of a patient developing a factor VIII antibody for the first time during pregnancy rather than in the postpartum period (Marengo-Rowe et al., 1972) . In most cases pregnancy and delivery were quite normal and the patients had been completely healthy. However, three patients had some evidence of an auto-immune disorder before the development of the inhibitor (Barkhan, 1952; Robboy et al., 1970) .
Clinical features differ slightly from those of haemophilia in that large ecchymoses, muscle bleeds, haematuria, menorrhagia, and retroperitoneal bleeds are more common than haemarthroses and may be fatal (Table) .
There are four reports of postpartum women with factor VIII inibitors in which further pregnancies are mentioned. In three of these (Hewlett and Haden, 1949; Conley et al., 1950; Margolius et al., 1961) there was some evidence of a continuing bleeding tendency during and after the subsequent pregnancy. In the fourth (Frick, 1953) , the severity of the bleeding increased during the subsequent pregnancy.
Conversely, our patient went into remission during her second pregnancy, indicating that pregnancy does not necessarily affect the natural progress of the disorder.
The babies born to mothers with pre-existing coagulation defects have all been clinically normal although in two cases the mothers were known to have detectable inhibitor and a clinical bleeding tendency at the time of birth (Frick, 1953; MarengoRowe et al., 1972 The thrombocytopenia, long bleeding time, and abnormal platelet retention in our patient were first noted in the last trimester after the titre of antibody to factor VIII had fallen and factor VIII:C was rising. They had all returned to normal by four weeks post partum. Platelet function tests were not performed earlier in the pregnancy.
Our patient had no evidence of an auto-immune disorder and, in particular, no detectable serum anti-platelet IgG or abnormal platelet surface IgG even when her platelet count was low and the platelet function abnormal. Acquired von Willebrand's disease was excluded by high VIIIR:AG, normal platelet aggregation with ristocetin, and normal VIII:WF.
The aetiology of this-disorder is unknown. It is thought that the pregnant mother can be sensitised to soluble fetal plasma proteins such as the lipoprotein allotypes (Durwald et al., 1965) but there is, at present, no definite experimental evidence that factor VIII antigenic allotypes exist. If the maternal immune system is stimulated by fetal factor VIII the antibody so formed must crossreact with maternal factor VIII if the bleeding tendency is to be explained. One would expect such an antibody to reappear after some of the subsequent pregnancies, as in Rhesus sensitisation, but relapses have not been reported. The variable nature of this disorder also argues in favour of a more complex pathogenesis.
There is not only an association between factor VIII antibodies and auto-immune disorders, such as rheumatoid arthritis and systemic lupus, but also a well-known alteration of immune reactivity in normal pregnancy. These two observations suggest that a likely explanation of postpartum factor VIII antibodies is that of a temporary breakdown in the mother's tolerance to her own factor VTII. Whether or not this is the case, this rare disorder does resemble other auto-immune states in its variable onset and duration, its varying severity, and in the fact that its aetiology is still a mystery.
